Navigation

'Referral advice' recommendation details

Atopic eczema in children

Results 1-10 of 16

Guidance ID NICE 'referral advice' recommendation 'Referral advice' category
CG57 Healthcare professionals should refer children with atopic eczema who follow a cow's milk-free diet for longer than 8 weeks for specialist dietary advice. Time frame not specified
CG57 Healthcare professionals should exclude secondary bacterial or viral infection if a mild or moderately potent topical corticosteroid has not controlled the atopic eczema within 7-14 days. In children aged 12 months or over, potent topical corticosteroids should then be used for as short a time as possible and in any case for no longer than 14 days. They should not be used on the face or neck. If this treatment does not control the atopic eczema, the diagnosis should be reviewed and the child referred for specialist dermatological advice. Time frame not specified
CG57 If eczema herpeticum (widespread herpes simplex virus) is suspected in a child with atopic eczema, treatment with systemic aciclovir should be started immediately and the child should be referred for same-day specialist dermatological advice. If secondary bacterial infection is also suspected, treatment with appropriate systemic antibiotics should also be started. Immediate
CG57 If eczema herpeticum involves the skin around the eyes, the child should be treated with systemic aciclovir and should be referred for same-day ophthalmological and dermatological advice. Immediate
CG57 Immediate (same-day) referral for specialist dermatological advice is recommended if eczema herpeticum is suspected in children. Immediate
CG57 Urgent (within 2 weeks) referral for specialist dermatological advice is recommended for children with atopic eczema if the atopic eczema is severe and has not responded to optimum topical therapy after 1 week or treatment of bacterially infected atopic eczema has failed. Urgent
CG57 Referral for specialist dermatological advice is recommended for children with atopic eczema if: - the diagnosis is, or has become, uncertain - management has not controlled the atopic eczema satisfactorily based on a subjective assessment by the child, parent or carer (for example, the child is having 1-2 weeks of flares per month or is reacting adversely to many emollients) - atopic eczema on the face has not responded to appropriate treatment - the child or parent/carer may benefit from specialist advice on treatment application (for example, bandaging techniques) - contact allergic dermatitis is suspected (for example, persistent atopic eczema or facial, eyelid or hand atopic eczema) - the atopic eczema is giving rise to significant social or psychological problems for the child or parent/carer (for example, sleep disturbance, poor school attendance) - atopic eczema is associated with severe and recurrent infections, especially deep abscesses or pneumonia. Time frame not specified
CG57 Children with atopic eczema that has responded to optimum management but for whom the impact of the atopic eczema on quality of life and psychosocial wellbeing has not improved should be referred for psychological advice. Time frame not specified
CG57 Children with moderate or severe atopic eczema and suspected food allergy should be referred for specialist investigation and management of the atopic eczema and allergy. Time frame not specified
CG57 Children with atopic eczema who fail to grow at the expected growth trajectory, as reflected by UK growth charts, should be referred for specialist advice relating to growth. Time frame not specified

This page was last updated: 22 August 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.